Outcomes following HDR Brachytherapy Boost for High Risk Localised Prostate Cancer: Data from a UK Centre

被引：0
|
作者：
Lorimer, C. [1 ]
Ravi, B. [1 ]
Cowtan, F. [1 ]
Johns, A. [1 ]
Robinson, A. [1 ]
Nikapota, A. [1 ]
机构：
[1] Univ Hosp Sussex NHS Trust, Brighton, England
来源：
CLINICAL ONCOLOGY | 2023年 / 35卷 / 02期
关键词：
DOSE-RATE BRACHYTHERAPY; INTERMEDIATE; MONOTHERAPY;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E241 / E241
页数：1
相关论文
共 50 条
  • [31] Outcomes of 11 Years of Prostate LDR Brachytherapy at a UK Centre
    Chadwick, E.
    Langley, S.
    Laing, R.
    CLINICAL ONCOLOGY, 2011, 23 (03) : S32 - S33
  • [32] Acute toxicities after combined radiotherapy (HDR brachytherapy and teletherapy) of localised prostate cancer
    Fehlauer, F.
    Basler, I.
    Vogt, E.
    Jozic, L.
    Gruen, A.
    Thurmann, H.
    Tribius, S.
    Alberti, W.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 118 - 118
  • [33] Ultrafractionated radiotherapy(RT) in localised prostate cancer:HDR brachytherapy vs stereotactic RT
    Tsang, Y. M.
    Tharmalingam, H.
    Belessiotis-Richards, K.
    Armstrong, S.
    Ostler, P.
    Hughes, R.
    Alonzi, R.
    Hoskin, P.
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S27 - S28
  • [34] MRI-guided Ultrafocal HDR-brachytherapy for Localised Prostate Cancer Reply
    van Son, Marieke Juliet
    Peters, Max
    Moerland, Marinus A.
    van Zyp, Jochem R. N. van der Voort
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (05): : 1183 - 1184
  • [35] Dose outside of the prostate is associated with improved outcomes for high-risk prostate cancer patients treated with brachytherapy boost
    Shortall, Jane
    Osorio, Eliana Vasquez
    Green, Andrew
    McWilliam, Alan
    Elumalai, Thriaviyam
    Reeves, Kimberley
    Johnson-Hart, Corinne
    Beasley, William
    Hoskin, Peter
    Choudhury, Ananya
    van Herk, Marcel
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [36] LDR versus HDR brachytherapy boost in prostate cancer patients - a retrospective analysis
    Rodda, S.
    Murray, L.
    Bottomley, D.
    Bownes, P.
    Wilkinson, C.
    Adiotomre, E.
    Al-Qaisieh, B.
    Dugdale, E.
    Hulson, O.
    Mason, J.
    Smith, J.
    Henry, A. M.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S587 - S587
  • [37] EXTERNAL BEAM RADIOTHERAPY WITH HDR BRACHYTHERAPY BOOST AND ANDROGEN DEPRIVATION FOR PROSTATE CANCER
    Miller, S.
    Bucci, J.
    Chin, Y.
    Malouf, D.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S24 - S24
  • [38] Long-term Experience of HDR Brachytherapy Boost for Localized Prostate Cancer
    Magnan, S.
    Despres, P.
    Martin, A.
    Foster, W.
    Aubin, S.
    Beaulieu, L.
    Vigneault, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S412 - S412
  • [39] Single dose high-dose rate (HDR) brachytherapy (BT) as monotherapy for localised prostate cancer: Early results of a UK national cohort study
    Tharmalingam, Hannah
    Tsang, Yatman
    Ostler, Peter
    Wylie, James
    Bahl, Amit
    Lydon, Anna
    Ahmed, Imtiaz
    Elwell, Christine
    Nikapota, Ashok R.
    Hoskin, Peter J.
    RADIOTHERAPY AND ONCOLOGY, 2020, 143 : 95 - 100
  • [40] Single-fraction HDR brachytherapy boost in combination to EBRT for prostate cancer
    Huertas, A.
    Blanchard, P.
    Calmels, L.
    Edouard, M.
    Bossi, A.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S710 - S710
12345